LOW INCIDENCE OF FEMORAL VASCULAR COMPLICATIONS WITH PRIMARY AND REPEAT PERCLOSE PRE-CLOSING FOR BALLOON AORTIC VALVULOPLASTY: DATA FROM A LARGE PARTNER-CONTEMPORARY SINGLE CENTER SERIES  by Doctor, Niraj et al.
E1347
JACC April 5, 2011
Volume 57, Issue 14
  VALVULAR HEART DISEASE
LOW INCIDENCE OF FEMORAL VASCULAR COMPLICATIONS WITH PRIMARY AND REPEAT 
PERCLOSE PRE-CLOSING FOR BALLOON AORTIC VALVULOPLASTY: DATA FROM A LARGE PARTNER-
CONTEMPORARY SINGLE CENTER SERIES
ACC Poster Contributions
Ernest N. Morial Convention Center, Hall F
Sunday, April 03, 2011, 3:30 p.m.-4:45 p.m.
Session Title: Valvular Disease-Precutaneous Therapies for Valvular Heart Disease
Abstract Category: 19. Valvular Disease
Session-Poster Board Number:  1050-73
Authors: Niraj Doctor, Hasan Jilaihawi, Tarun Chakravarty, Kashif Mohammad, Mamta Buch, Jasminka Stegic, Raj Makkar, cedars-sinai medical 
center, los angeles, CA
Background:  The control group of cohort B of the US-PARTNER trial demonstrated a low incidence of procedural complications in patients 
undergoing balloon aortic valvuloplasty (BAV). We sought to specifically assess the incidence of femoral vascular complications in the setting of a 
default perclose pre-closing strategy in a large balloon aortic valvuloplasty population that was contemporary and overlapping with our recruitment 
to the US-PARTNER trial.
Methods:  The safety and efficacy of perclose preclosing was assessed in patients undergoing BAV in our center. The incidence of peripheral 
vascular complications was assessed.
Results:  Between the 30th of November 2007 and the 14th of September 2010, 163 consecutive patients underwent a total of 181 BAV 
procedures using a Z-med balloon with a routine femoral pre-closing strategy; 123(67.9%) were with 11F sheath access, 42(23.2%) 12F and 
16(8.8%)14F. Mean age was 83.7 (SD 7.6) and 50.8% were male. Immediate hemostasis was obtained in 161 cases (89.0%), and of the remainder 
8 required an additional device, 9 manual compression and 3 had oozing post-procedure. Hematoma was seen in 4 cases (2.2%), with no AV fistula, 
pseudoaneurysm or vascular rupture and no access site infection. By VARC criteria, major access complication occurred in only one cases (0.6%), 
a femoral artery occlusion treated with surgical endarterectomy. There was suboptimal preclosing in 22 cases (12.2%) but this was driven by need 
for an additional closure device at the end of the procedure or compression. In 12 cases there was prior preclosing for BAV by the same side with 
an optimal result in all cases except one with some oozing post-procedure. Suboptimal result was unrelated to sheath size, prior preclosing on the 
same side, sex, diabetes, age, BMI, weight adjusted heparin dose and ACT.
Conclusion: Percutaneous suture mediated closure with the Perclose device is an effective method for achieving hemostasis and contributes 
significantly to the safety of balloon aortic valvuloplasty in the present era. Repeated preclosing to the same vessel appears safe and effective.
